Pancreatic adenocarcinoma : What is the real outcome of patients with major response to neoadjuvant treatment ?

Objectives Neoadjuvant treatment (NT) consisting in chemotherapy or radio chemotherapy is efficient in borderline (BL) and locally advanced (LA) pancreatic cancer (PC) , allowing a higher rate of R0 resection. It has been shown that a major response (downstaging to T0 and T1 tumors) is a good prognostic factor , but real outcome of these patients has been poorly described.

Source: Pancreatology - June 1, 2018 Category: Gastroenterology Authors: Etienne Buscail, Pauline Jaffrezic, Veronique Vendrely, Sandrine Dabernat, Jean-Phillipe Adam, Christophe Laurent, Laurence Chiche Tags: 5. Pancreatic Cancer II Source Type: research